[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]
- PMID: 26899776
- DOI: 10.1016/j.revmed.2016.01.005
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion]
Abstract
Purpose: To develop French recommendations about the management of vaccinations, the screening of cervical cancer and the prevention of pneumocystis pneumonia in systemic lupus erythematosus (SLE).
Methods: Thirty-seven experts qualified in internal medicine, rheumatology, dermatology, nephrology and pediatrics have selected recommendations from a list of proposition based on available data from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified.
Results: Inactivated vaccines do not cause significant harm in SLE patients. Experts recommend that lupus patient should receive vaccinations accordingly to the recommendations and the schedules for the general public. Pneumococcal vaccination is recommended for all SLE patients. Influenza vaccination is recommended for immunosuppressed SLE patients. Live attenuated vaccines should be avoided in immunosuppressed patients. Yet, recent works suggest that they can be considered in mildly immunosuppressed patients. Experts have recommended a cervical cytology every year for immunosuppressed patients. No consensus was obtained for the prevention of pneumocystis pneumonia.
Conclusion: These recommendations can be expected to improve clinical practice uniformity and, in the longer term, to optimize the management of SLE patients.
Keywords: Guidelines; Infection; Lupus systémique; Recommandations; Systemic lupus erythematosus; Vaccination.
Copyright © 2016 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
Similar articles
-
[Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].Rev Med Interne. 2015 Jun;36(6):372-80. doi: 10.1016/j.revmed.2014.10.009. Epub 2014 Nov 14. Rev Med Interne. 2015. PMID: 25455954 French.
-
Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.Semin Arthritis Rheum. 2015 Jun;44(6):666-71. doi: 10.1016/j.semarthrit.2015.01.002. Epub 2015 Jan 22. Semin Arthritis Rheum. 2015. PMID: 25701500 Free PMC article.
-
Recommendations and barriers to vaccination in systemic lupus erythematosus.Autoimmun Rev. 2018 Oct;17(10):990-1001. doi: 10.1016/j.autrev.2018.04.006. Epub 2018 Aug 11. Autoimmun Rev. 2018. PMID: 30103044 Free PMC article. Review.
-
Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1. J Rheumatol. 2018. PMID: 30173152
-
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.J Low Genit Tract Dis. 2019 Apr;23(2):87-101. doi: 10.1097/LGT.0000000000000468. J Low Genit Tract Dis. 2019. PMID: 30907775
Cited by
-
Systemic lupus erythematosus: state of the art on clinical practice guidelines.RMD Open. 2018 Nov 27;4(2):e000793. doi: 10.1136/rmdopen-2018-000793. eCollection 2018. RMD Open. 2018. PMID: 30564454 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical